Acutus Medical Inc (OQ:AFIB)

Apr 01, 2024 04:05 pm ET
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023. Recent Highlights: Announced strategic realignment of resources and corporate restructuring on...
Nov 10, 2023 04:01 pm ET
Acutus Medical to Cancel Third Quarter 2023 Conference Call
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November...
Nov 08, 2023 04:01 pm ET
Acutus Medical Reports Third Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter revenue of $5.2 million grew 44% year-over-year, led by strong growth in distribution revenue...
Nov 08, 2023 04:00 pm ET
Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens, Chairman of Acutus, commented, “Following an extensive strategic review by the Company’s...
Nov 02, 2023 04:13 pm ET
Acutus Medical to Announce Third Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial results on Monday,...
Nov 02, 2023 04:05 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on November 1, 2023 that were approved by the...
Oct 02, 2023 04:05 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on October 1, 2023 that were approved by the...
Aug 07, 2023 04:01 pm ET
Acutus Medical Reports Second Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2023. Recent...
Aug 01, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on August 1, 2023 that were approved by the...
Jul 27, 2023 07:00 am ET
Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 43rd Annual Canaccord Growth...
Jul 24, 2023 04:01 pm ET
Acutus Medical to Announce Second Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its second quarter 2023 financial results on Monday,...
Jul 03, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on July 1, 2023 that were approved by the...
Jun 01, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2023 that were approved by the...
May 15, 2023 09:00 am ET
Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, is pleased to announce its participation in the upcoming Heart Rhythm Society (HRS) Annual...
May 11, 2023 04:01 pm ET
Acutus Medical Reports First Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2023. Recent Highlights:...
May 02, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on May 1, 2023 that were approved by the...
Apr 28, 2023 05:15 pm ET
Acutus Medical to Announce First Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its first quarter 2023 financial results on Thursday,...
Apr 20, 2023 08:01 am ET
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the first quarter 2023...
Apr 20, 2023 08:00 am ET
RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced results from the RECOVER AF study. The study, published online in EP...
Apr 03, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on April 1, 2023 that were approved by the...
Mar 20, 2023 02:00 pm ET
Sidoti's Small-Cap Virtual March Conference
NEW YORK, NY / ACCESSWIRE / March 15, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 22-23, 2023. The links can also be found at www.sidoticonference.com/events.
Mar 16, 2023 04:01 pm ET
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended...
Mar 09, 2023 04:01 pm ET
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its fourth quarter and full year 2022 financial...
Mar 01, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on March 1, 2023 that were approved by the...
Feb 06, 2023 06:00 am ET
Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced results from the AcQForce Flutter Study “AcQForce Flutter: Force Sensing RF...
Feb 01, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on February 1, 2023 that were approved by the...
Jan 09, 2023 06:00 am ET
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the fourth quarter and...
Jan 03, 2023 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on January 1, 2023 that were approved by the...
Dec 29, 2022 06:00 am ET
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the acceptance of the AcQForce Flutter abstract titled “AcQForce Flutter...
Dec 21, 2022 06:00 am ET
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that the Company has achieved the second milestone under...
Dec 19, 2022 06:00 am ET
Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the full commercial release of AcQMap 8.5. This next generation software...
Dec 06, 2022 06:00 am ET
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
Acutus Medical, Inc. (“Acutus” or “the Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced receipt of a CE Mark issued under the European Union (EU)...
Dec 01, 2022 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on December 1, 2022 that were approved by the...
Nov 10, 2022 04:01 pm ET
Acutus Medical Reports Third Quarter 2022 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2022. Recent Updates:...
Nov 03, 2022 10:53 am ET
Thinking about buying stock in Netflix, Barrick Gold, Sunrun, Acutus Medical, or Robinhood Markets?
NEW YORK, Nov. 3, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NFLX, GOLD, RUN, AFIB, and HOOD.
Nov 03, 2022 08:00 am ET
Acutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to Medtronic
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that the Company has achieved the first milestone under...
Nov 01, 2022 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on November 1, 2022 that were approved by the...
Oct 27, 2022 04:01 pm ET
Acutus Medical to Announce Third Quarter 2022 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2022 financial results on Thursday,...
Oct 18, 2022 06:00 am ET
Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced submission of pivotal clinical data from the AcQForce...
Oct 03, 2022 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on October 1, 2022 that were approved by the...
Sep 07, 2022 08:30 am ET
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council
BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennekens, executive...
Sep 01, 2022 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted an equity award on September 1, 2022 that was approved by the...
Aug 24, 2022 02:51 pm ET
SHAREHOLDER UPDATE: Glancy Prongay & Murray LLP Appointed Lead Counsel in Securities Class Action Against Acutus Medical, Inc.
Glancy Prongay & Murray LLP (“GPM”) announces that it has been appointed Lead Counsel in the securities class action against Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:
Aug 11, 2022 04:05 pm ET
Acutus Medical Reports Second Quarter 2022 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2022. Recent Updates:...
Aug 02, 2022 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on August 1, 2022 that were approved by the...
Jul 28, 2022 04:01 pm ET
Acutus Medical to Announce Second Quarter 2022 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its second quarter 2022 financial results on Thursday,...
Jul 27, 2022 09:31 am ET
Thinking about buying stock in Sundial Growers, Marathon Digital, Riot Blockchain, Acutus Medical, or Helix Energy Solutions?
NEW YORK, July 27, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, MARA, RIOT, AFIB, and HLX.
Jul 27, 2022 06:30 am ET
Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced approval of its AcQMap High Resolution Imaging and Mapping System and the...
Jul 21, 2022 09:35 am ET
Thinking about buying stock in AMC Entertainment, Ford Motor Company, Deutsche Bank, Acutus Medical, or Las Vegas Sands?
NEW YORK, July 21, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, F, DB, AFIB, and LVS.
Jul 21, 2022 06:30 am ET
Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that David Roman has been appointed President and Chief...
Jul 01, 2022 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on July 1, 2022 that were approved by the...
Jul 01, 2022 06:30 am ET
Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the completion of the first of two closings for its...
Jun 27, 2022 08:30 am ET
Thinking about buying stock in Epizyme, Acutus Medical, Agile Therapeutics, Axsome Therapeutics, or Evofem Biosciences?
NEW YORK, June 27, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EPZM, AFIB, AGRX, AXSM, and EVFM.
Jun 27, 2022 06:00 am ET
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery System
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the commercial launch of an expanded suite of left-heart access products to...
Jun 01, 2022 04:01 pm ET
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2022 that were approved by the...
May 13, 2022 08:00 am ET
Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System
Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced successful completion of patient enrollment in the company’s AcQForce™ Flutter...
May 12, 2022 04:01 pm ET
Acutus Medical Reports First Quarter 2022 Financial Results and CEO Transition
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2022 and announced a...
May 09, 2022 11:50 am ET
Lifshitz Law PLLC. Announces Investigations of Acutus Medical, Inc. (NASDAQ: AFIB), Butterfly Network, Inc. (NYSE: BFLY), Pulse Biosciences, inc. (NASDAQ: PLSE), and SunPower Corporation (NASDAQ: SPWR
Acutus Medical, Inc. (NASDAQ: AFIB) Lifshitz Law PLLC announces that a class action complaint has been filed against Acutus Medical alleging that, throughout the Class Period, Acutus Medical made false and misleading statements and failed to...
Apr 27, 2022 04:01 pm ET
Acutus Medical to Announce First Quarter 2022 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its first quarter 2022 financial results on Thursday,...
Apr 27, 2022 10:01 am ET
Thinking about buying stock in Mattel, Zentalis Pharmaceuticals, Acutus Medical, Allogene Therapeutics, or NeoGenomics?
NEW YORK, April 27, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MAT, ZNTL, AFIB, ALLO, and NEO.
Apr 27, 2022 06:30 am ET
Acutus Medical Announces Agreements to Fund Strategic Growth Priorities
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a commitment letter from Deerfield Management Company...
Apr 18, 2022 10:15 am ET
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, April 18, 2022 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. ("Acutus" or "the Company") (NASDAQ: AFIB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 18, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, April 18, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Apr 17, 2022 11:00 am ET
FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses Over $100K to Secure Counsel Before Important April 18 Deadline in Securities Class Action
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead...
Apr 15, 2022 09:00 pm ET
ACUTUS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Acutus Medical Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Acutus Medical Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) in the United States District Court for the Southern District of California on behalf of all persons and entities who purchased or otherwise acquired Acutus securities between May 13, 2021 and November 11, 2021, both dates inclusive (the “Class Period”). Investors have until April 18, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Apr 15, 2022 01:00 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:
Apr 15, 2022 04:45 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, April 15, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Apr 14, 2022 11:00 am ET
AFIB Investors Have Opportunity to Lead Acutus Medical, Inc. Securities Fraud Lawsuit
LOS ANGELES, April 14, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB).
Apr 14, 2022 05:45 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, April 14, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Apr 14, 2022 12:04 am ET
MONDAY DEADLINE: Acutus Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, April 14, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announced that purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, inclusive (the "Class Period") have this upcoming Monday, April 18, 2022 to seek appointment as lead plaintiff in the Acutus Medical class action lawsuit.  Robbins Geller represents the plaintiff in the first-filed complaint, Brown v. Acutus Medical, Inc., No. 22-cv-00206 (S.D. Cal.), which charges Acutus Medical and certain of its top executives with violations of the Securities Exchange Act o
Apr 13, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, April 13, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acutus Medical, Inc..
Apr 12, 2022 11:54 am ET
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 18 Deadline in Securities Class Action – A
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead...
Apr 12, 2022 11:00 am ET
AFIB Investors Have Opportunity to Lead Acutus Medical, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., April 12, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB).
Apr 12, 2022 05:45 am ET
AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders
NEW YORK, April 12, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws.
Apr 11, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acutus, Pulse, SunPower, and Butterfly and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acutus Medical, Inc. (NASDAQ: AFIB), Pulse Biosciences, Inc. (NASDAQ: PLSE),...
Apr 11, 2022 11:45 am ET
DEADLINE ALERT for AFIB, SPWR, PLSE, and BFLY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Apr 11, 2022 08:35 am ET
(AFIB) Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Acutus Class Action Lawsuit
Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB). The class action is on behalf of shareholders who...
Apr 11, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, April 11, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Apr 10, 2022 11:15 am ET
FINAL DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action - AFIB
NEW YORK, April 10, 2022 /PRNewswire/ --
Apr 08, 2022 02:09 pm ET
Acutus, Inc Investors: Please contact the Portnoy Law Firm to recover losses
The Portnoy Law Firm advises Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) investors that a class action lawsuit filed on behalf of investors that purchased Acutus shares between May 13, 2021 and November 11, 2021. Investors are...
Apr 08, 2022 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Acutus Medical, Inc. (“Acutus” or the...
Apr 08, 2022 10:22 am ET
ASTR, HOL; AFIB; & BFLY Upcoming Deadline Reminders: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions and Encourages Shareholders to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Apr 08, 2022 05:45 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, April 8, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Apr 07, 2022 03:42 pm ET
AFIB DEADLINE ALERT: ROSEN, A TOP RANKED FIRM, Encourages Acutus Medical, Inc. Investors to Secure Counsel Before Important April 18 Deadline in Securities Class Action – AFIB
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead...
Apr 07, 2022 12:00 pm ET
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Apr 07, 2022 10:07 am ET
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Acutus Medical, Inc. (AFIB) Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Acutus Medical, Inc. (“Acutus Medical” or the “Company”)...
Apr 07, 2022 05:45 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, April 7, 2022 /PRNewswire/ --  April 7, 2022 – Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Apr 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fennec, Astra, Acutus, and Pulse and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fennec Pharmaceuticals, Inc. (NASDAQ: FENC), Astra Space, Inc. (NASDAQ: ASTR),...
Apr 06, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Acutus Medical, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, April 6, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acutus Medical, Inc..
Apr 05, 2022 05:45 am ET
AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders
NEW YORK, April 5, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws.
Apr 04, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, April 4, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Apr 03, 2022 04:10 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acutus Medical, Inc., of Class Action Lawsuit and Upcoming Deadline - AFIB
NEW YORK, April 3, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) and certain of its officers.  The class action, filed in the United States District Court for the Southern District of California, and docketed under 22-cv-00388, is on behalf of a class consisting of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021, inclusive (the "Class Period"), seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act").
Apr 03, 2022 02:15 pm ET
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead...
Apr 01, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telos, Fennec, Astra, and Acutus and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telos Corporation (NASDAQ: TLS), Fennec Pharmaceuticals, Inc. (NASDAQ: FENC),...
Apr 01, 2022 05:04 pm ET
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AFIB
NEW YORK, April 1, 2022 /PRNewswire/ --
Apr 01, 2022 10:18 am ET
ASTR, HOL; AFIB; & BFLY Investor Reminder: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Actions Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Apr 01, 2022 08:02 am ET
(AFIB) Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Acutus Class Action Lawsuit
Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB). The class action is on behalf of shareholders who...
Apr 01, 2022 05:45 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Mar 31, 2022 04:01 pm ET
Acutus Medical to Present at the 21st Annual Needham Virtual Healthcare Conference
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 21st Annual Needham Virtual...
Mar 31, 2022 12:00 pm ET
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 31, 2022 05:45 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 31, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Mar 30, 2022 07:33 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acutus Medical, Inc., of Class Action Lawsuit and Upcoming Deadline – AFIB
Pomerantz LLP announces that a class action lawsuit has been filed against Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) and certain of its officers.   The class action, filed in the United States District Court for the Southern...
Mar 30, 2022 04:01 pm ET
Acutus Medical Reports Fourth Quarter and Full Year 2021 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December...
Mar 30, 2022 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Acutus Medical, Inc. (“Acutus” or the...
Mar 30, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, March 30, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acutus Medical, Inc..
Mar 29, 2022 05:45 am ET
AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders
NEW YORK, March 29, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws.
Mar 28, 2022 01:00 pm ET
DEADLINE ALERT for FENC, AFIB, SPWR, and PLSE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 28, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, March 28, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Mar 27, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telos, Fennec, Astra, and Acutus and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telos Corporation (NASDAQ: TLS), Fennec Pharmaceuticals, Inc. (NASDAQ: FENC),...
Mar 25, 2022 10:14 am ET
ASTR, HOL; AFIB; & BFLY Investor Reminder: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions and Upcoming Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Mar 25, 2022 05:45 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders Of A Lead Plaintiff Deadline Of April 18, 2022
NEW YORK, March 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Mar 24, 2022 01:20 pm ET
SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of Acutus Medical Inc. (AFIB) and Encourages Investors with More than $300,000 in Losses to Contact the Firm
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a securities class action on behalf of investors who purchased or otherwise acquired common stock of Acutus Medical Inc....
Mar 24, 2022 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Acutus Medical, Inc. (“Acutus” or the...
Mar 24, 2022 05:45 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 24, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Mar 23, 2022 11:00 am ET
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 23, 2022 06:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, March 23, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acutus Medical, Inc..
Mar 22, 2022 06:00 am ET
AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders
NEW YORK , March 22, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws.
Mar 21, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telos, Fennec, Astra, and Acutus and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telos Corporation (NASDAQ: TLS), Fennec Pharmaceuticals, Inc. (NASDAQ: FENC),...
Mar 21, 2022 12:00 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Acutus Medical, Inc. (AFIB) Investors
LOS ANGELES, March 21, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, inclusive (the "Class Period").  Acutus investors have until April 18, 2022 to file a lead plaintiff motion.
Mar 21, 2022 06:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, March 21, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Mar 18, 2022 11:00 am ET
DEADLINE ALERT for FENC, AFIB, SPWR, and PLSE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 18, 2022 10:09 am ET
ASTR, HOL; AFIB; & BFLY Investor Reminder: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Reminds Investors of Upcoming Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Mar 18, 2022 06:00 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, March 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Mar 17, 2022 04:31 pm ET
AFIB UPCOMING DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Acutus Medical, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit
SAN DIEGO, March 17, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, both dates inclusive (the "Class Period") and charging Acutus Medical and certain of its top executives with violations of the Securities Exchange Act of 1934. The Acutus Medical class action lawsuit – captioned Brown v. Acutus Medical, Inc., No. 22-cv-00206 (S.D. Cal.) – was commenced on February 15, 2022.
Mar 17, 2022 04:00 pm ET
Acutus Medical Updates Time and Date of Fourth Quarter and Full Year 2021 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today updated the planned release of its fourth quarter and full year 2021...
Mar 17, 2022 06:00 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 17, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Mar 16, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acutus, Pulse, SunPower, and Butterfly and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acutus Medical, Inc. (NASDAQ: AFIB), Pulse Biosciences, Inc. (NASDAQ: PLSE),...
Mar 16, 2022 11:00 am ET
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 16, 2022 06:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, March 16, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acutus Medical, Inc..
Mar 15, 2022 10:45 am ET
Investor Notice: Lawsuit for Investors who Lost over $50,000 in Acutus Medical, Inc shares announced by Shareholders Foundation
SAN DIEGO, March 15, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Acutus Medical, Inc. (NASDAQ: AFIB) shares.
Mar 15, 2022 06:00 am ET
AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders
NEW YORK, March 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws.
Mar 14, 2022 04:21 pm ET
AFIB NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AFIB
NEW YORK, March 14, 2022 /PRNewswire/ --
Mar 14, 2022 11:00 am ET
AFIB Investors Have Opportunity To Lead Acutus Medical, Inc. Securities Fraud Lawsuit
LOS ANGELES, March 14, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB).
Mar 14, 2022 06:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, March 14, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Mar 12, 2022 03:27 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acutus Medical, Inc. - AFIB
Pomerantz LLP is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Mar 12, 2022 09:00 am ET
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead...
Mar 11, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Astra, Acutus, Pulse, and SunPower and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Astra Space, Inc. (NASDAQ: ASTR), Acutus Medical, Inc. (NASDAQ: AFIB), Pulse...
Mar 11, 2022 02:00 pm ET
DEADLINE ALERT for FENC, AFIB, SPWR, and PLSE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 11, 2022 10:03 am ET
ASTR, HOL; AFIB; & BFLY Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Reminds Investors of Upcoming Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Mar 11, 2022 05:00 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, March 11, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Mar 10, 2022 04:01 pm ET
Acutus Medical to Announce Fourth Quarter and Full-Year Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its fourth quarter and full-year 2021 financial...
Mar 10, 2022 09:30 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Acutus Medical, Inc. (“Acutus” or the...
Mar 10, 2022 05:00 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 10, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Mar 09, 2022 02:00 pm ET
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
\Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 09, 2022 05:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, March 9, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Acutus Medical, Inc..
Mar 08, 2022 05:00 am ET
AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders
NEW YORK, March 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws.
Mar 07, 2022 04:48 pm ET
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead...
Mar 07, 2022 10:00 am ET
AFIB Investors Have Opportunity to Lead Acutus Medical, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., March 7, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB).
Mar 07, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, March 7, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Mar 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telos, Fennec, Astra Space, and Acutus and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telos Corporation (NASDAQ: TLS), Fennec Pharmaceuticals, Inc. (NASDAQ: FENC),...
Mar 06, 2022 05:12 am ET
ROSEN, A TOP RANKED FIRM, Encourages Acutus Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AFIB
NEW YORK, March 6, 2022 /PRNewswire/ --
Mar 04, 2022 09:18 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Acutus Medical, Inc. – AFIB
Pomerantz LLP is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Mar 04, 2022 07:12 pm ET
ACUTUS MEDICAL UPDATE: Berger Montague Investigates Securities Fraud Allegations Against Acutus Medical, Inc. (NASDAQ: AFIB); Lead Plaintiff Deadline is April 18, 2022
PHILADELPHIA, March 4, 2022 /PRNewswire/ -- Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities of Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021 (the "Class Period").
Mar 04, 2022 10:22 am ET
AFIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Notifies Acutus Medical, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Acutus Medical, Inc. (“Acutus Medical” or the “Company”) (NASDAQ: AFIB) and certain of its officers, on behalf of...
Mar 04, 2022 05:00 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, March 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Mar 03, 2022 10:00 am ET
DEADLINE ALERT for FENC, AFIB, SPWR, and PLSE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 03, 2022 05:00 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors Of A Class Action Lawsuit And Upcoming Deadline
NEW YORK, March 3, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Mar 02, 2022 05:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, March 2, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Acutus Medical, Inc..
Mar 01, 2022 12:06 pm ET
Acutus Medical Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Acutus Medical
Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). A complaint has been filed on behalf of investors who purchased or otherwise acquired...
Mar 01, 2022 12:00 pm ET
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 01, 2022 05:00 am ET
AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders
NEW YORK, March 1, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws.
Feb 28, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acutus, Pulse, SunPower, and Butterfly and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acutus Medical, Inc. (NASDAQ: AFIB), Pulse Biosciences, Inc. (NASDAQ: PLSE),...
Feb 28, 2022 07:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acutus Medical, Inc. - AFIB
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB). Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Feb 28, 2022 01:24 pm ET
ROSEN, A LEADING LAW FIRM, Encourages Acutus Medical, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead plaintiff deadline.
Feb 28, 2022 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:
Feb 28, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Feb 26, 2022 09:21 am ET
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead...
Feb 25, 2022 03:00 pm ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
Law Offices of Howard G. Smith reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”).
Feb 25, 2022 10:48 am ET
AFIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Notifies Acutus Medical, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Acutus Medical, Inc. (“Acutus Medical” or the “Company”) (NASDAQ: AFIB) and certain of its officers, on behalf of...
Feb 25, 2022 05:00 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Feb 24, 2022 07:22 pm ET
ROSEN, A LEADING LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AFIB
NEW YORK, Feb. 24, 2022 /PRNewswire/ --
Feb 24, 2022 01:40 pm ET
ACUTUS MEDICAL, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against in the United States District Court for the
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of investors who purchased or otherwise acquired...
Feb 24, 2022 05:00 am ET
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 24, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit.
Feb 23, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Instadose, Astra Space, Acutus, and Pulse and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Instadose Pharma Corp. (OTCMKTS: INSD), Astra Space, Inc. (NASDAQ: ASTR), Acutus...
Feb 23, 2022 03:01 pm ET
Acutus, Inc. Investors: Please contact the Portnoy Law Firm to recover losses
The Portnoy Law Firm advises Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) investors that a class action lawsuit filed on behalf of investors that purchased Acutus shares between May 13, 2021 and November 11, 2021. Investors are...
Feb 23, 2022 01:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Acutus Medical, Inc. (AFIB) Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:
Feb 23, 2022 11:00 am ET
AFIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Notifies Acutus Medical, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Acutus Medical, Inc. (“Acutus Medical” or the “Company”) (NASDAQ: AFIB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Acutus Medical securities between May 13, 2021 and November 11, 2021, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
Feb 23, 2022 05:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)
NEW YORK, Feb. 23, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Acutus Medical, Inc..
Feb 22, 2022 07:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acutus Medical, Inc. - AFIB
Pomerantz LLP is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Feb 22, 2022 02:20 pm ET
ROSEN, A LONGSTANDING LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the...
Feb 22, 2022 10:00 am ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Acutus Medical, Inc. (AFIB) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”). Acutus investors have until April 18, 2022 to file a le
Feb 22, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, Feb. 22, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders:
Feb 21, 2022 06:32 pm ET
AFIB ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Acutus Medical, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit
SAN DIEGO, Feb. 21, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, both dates inclusive (the "Class Period") and charging Acutus Medical and certain of its top executives with violations of the Securities Exchange Act of 1934.  The Acutus Medical class action lawsuit was commenced in the Southern District of California on February 15, 2022 and it is captioned Brown v. Acutus Medical, Inc.,
Feb 21, 2022 10:41 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. (“Acutus” or “the Company”) (NASDAQ:
Feb 19, 2022 06:03 pm ET
AFIB NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Acutus Medical, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
The law firm of Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, both dates inclusive (the “Class Period”) and chargi
Feb 18, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telos, Fennec, Astra Space, and Acutus and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telos Corporation (NASDAQ: TLS), Fennec Pharmaceuticals, Inc. (NASDAQ: FENC),...
Feb 18, 2022 07:29 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. (“Acutus” or “the Company”) (NASDAQ:
Feb 18, 2022 12:00 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Acutus Medical, Inc. (AFIB) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:
Feb 18, 2022 08:30 am ET
AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022
NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB).
Feb 17, 2022 04:38 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Acutus Medical, Inc. (AFIB)
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) in the United States District Court for the Southern District of California on behalf of...
Feb 17, 2022 01:47 pm ET
Shareholder Alert: Robbins LLP Informs Investors that Acutus Medical, Inc. (AFIB) is Being Sued for Misleading Shareholders
The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, for violations of the Securities Exchange Act of 1934. Acutus is an arrhythmia management comp
Feb 17, 2022 12:19 pm ET
EQUITY ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AFIB
NEW YORK, Feb. 17, 2022 /PRNewswire/ --
Feb 17, 2022 11:00 am ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Acutus Medical, Inc. (AFIB) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:
Feb 17, 2022 09:00 am ET
AFIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Notifies Acutus Medical, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
NEW YORK, Feb. 17, 2022 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Acutus Medical, Inc. ("Acutus Medical" or the "Company") (NASDAQ: AFIB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Acutus Medical securities between May 13, 2021 and November 11, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/afib.
Feb 17, 2022 02:05 am ET
AFIB DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Acutus Medical, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
SAN DIEGO, Feb. 17, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, inclusive (the "Class Period") and charging Acutus Medical and certain of its top executives with violations of the Securities Exchange Act of 1934.  The Acutus Medical class action lawsuit was commenced on February 15, 2022 in the Southern District of California and is captioned Brown v. Acutus Medical, Inc., No. 22-cv-002
Feb 16, 2022 09:17 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acutus Medical, Inc. - AFIB
Pomerantz LLP is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Feb 16, 2022 09:00 pm ET
ACUTUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Acutus Medical Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Acutus Medical Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) in the United States District Court for the Southern District of California on behalf of all persons and entities who purchased or otherwise acquired Acutus securities between May 13, 2021 and November 11, 2021, both dates inclusive (the “Class Period”). Investors have until April 18, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Feb 16, 2022 06:04 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Acutus Medical, Inc. (AFIB) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) investors concerning the Company’s possible violations of federal securities laws.
Feb 16, 2022 03:57 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Acutus Medical, Inc. (AFIB) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:
Feb 16, 2022 02:59 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Acutus Medical, Inc. (AFIB)
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) in the United States District Court for the Southern District of California on behalf of...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More